Rheumnow
A Phase 3 Trial of a JAKi in Patients With Giant Cell Arteritis Sponsored by AbbVie Medical Affairs + Health Impact
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:49
- Mas informaciones
Informações:
Sinopsis
Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including efficacy and safety outcomes.
